-+ 0.00%
-+ 0.00%
-+ 0.00%

CTT Pharma wins US patent for micelle-based nicotine, vitamin, caffeine delivery technology

PUBT·08/10/2026 10:01:48
Listen to the news
CTT Pharma wins US patent for micelle-based nicotine, vitamin, caffeine delivery technology
  • CTT Pharmaceutical Holdings received a U.S. continuation-in-part patent covering micelle-based delivery for nicotine, vitamins, and caffeine.
  • The patent is set to issue Aug. 11, 2026, expanding protection for the company’s delivery technology.
  • The coverage supports multiple oral formats, including dissolvable strips, gum, and pouches.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CTT Pharmaceutical Holdings Inc. published the original content used to generate this news brief via TheNewswire (Ref. ID: 202608100600TNWSWRCACNPR_____1BNMFyeaK) on August 10, 2026, and is solely responsible for the information contained therein.